Medicamen Biotech P/B Ratio

Current P/B Ratio
1.51
Moderate Valuation
Moderate - Reasonably valued relative to book value

Medicamen Biotech (MEDICAMEQ) P/B ratio is 1.51 (Moderate), book value per share ₹197.14 vs Healthcare average P/B of -0.01 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see MEDICAMEQ stock price BSE.

Current Valuation Metrics

P/B Ratio 1.51
Current Price ₹345.50
Book Value/Share ₹197.14
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹276 Cr
Share Capital ₹14 Cr
Reserves & Surplus ₹262 Cr
Outstanding Shares 14,000,000
Book Value per Share ₹197.14

Valuation Signal

Signal Fairly Valued
Historical Avg 3.61
Historical Range 1.75 - 6.78
Percentile 0.0%

Sector Context

Sector Average -0.01
Sector Median 0.62
Sector Rank #11 of 50
Sector Percentile 22.0%

MEDICAMEQ P/B Ratio — Valuation Insights & Book Value Analysis

Medicamen Biotech price-to-book ratio interpretation, valuation status and historical context — current P/B 1.51 (Moderate). Explore MEDICAMEQ true value to estimate fundamental worth using multiple valuation models.

  • Current PB is 58.1% below historical average
  • Trading at premium to sector average PB of -0.01

Medicamen Biotech P/B Ratio Historical Trend

MEDICAMEQ annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read MEDICAMEQ dividend yield for the complete payout history and dividend yield track record.

MEDICAMEQ Historical P/B Ratio — Book Value Per Share & Year-End Price

Medicamen Biotech annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 1.75 ₹197.14 ₹345.50 ₹276 Moderate
2025 2.23 ₹163.85 ₹364.65 ₹213 Moderate
2024 3.22 ₹159.23 ₹512.45 ₹207 High
2023 4.06 ₹148.46 ₹603.15 ₹193 High
2022 6.78 ₹122.5 ₹830.50 ₹147 High

MEDICAMEQ vs Healthcare Peers — P/B Ratio Comparison

Medicamen Biotech P/B 1.51 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.

Sector Average
-0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.09
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.0 ₹65 Low
Krebs Biochemicals & Ind… KREBSBIO -0.82 ₹129 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.21 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low